Hyperfine Research has received 510(k) clearance from the US Food and Drug Administration (FDA) for the Swoop Portable MR imaging device.

The Swoop system, which is designed to be a point-of-care MR imaging device, wheels directly to the patient’s bedside. It can be plugged into a standard electrical wall outlet and can be controlled using a wireless tablet.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The FDA clearance for the device includes enhanced imaging and software and extends Hyperfine’s brain imaging indication to include patients aged between zero and two.

The company’s latest-generation device Swoop incorporates user feedback and technological upgrades, evolving from the original device, which was cleared by the FDA in February.

Hyperfine Research founder and chairman Jonathan Rothberg said: “Six years ago, we had a crazy vision to create a new product category for imaging – an affordable point-of-care MRI system.

“With this clearance from the FDA, we are launching an astonishing new diagnostic tool for patients and providers in our Swoop Portable MRI and we are delivering on our mission to democratise healthcare across clinical settings and geographies.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

According to the company, the Swoop system addresses the drawbacks of the existing imaging technologies and makes MRI more accessible to patients at all times and anywhere.

It is designed as a complementary system to traditional MRIs and enables critical decision-making in a variety of clinical settings by performing scans at the patient’s bedside and delivering results in minutes.

The complete Hyperfine system costs less than the annual service contract alone for most existing MRI systems, noted the company.

Hyperfine is currently offering the device for commercial purchase and the shipments are expected to begin shortly.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact